Welcome to our dedicated page for Nature’S Sun news (Ticker: NATR), a resource for investors and traders seeking the latest updates and insights on Nature’S Sun stock.
Nature’s Sunshine Products, Inc. (NASDAQ: NATR) is a natural health and wellness company that manufactures and distributes herbal, nutritional and personal care products in more than 40 countries. As a public company listed on the Nasdaq Capital Market, it regularly releases news that covers product innovation, regional performance, capital markets activity and leadership changes.
Investors and observers following NATR news can expect updates on financial results, including quarterly net sales by segment across Asia, Europe, North America and Latin America & Other, along with commentary on gross margins, adjusted EBITDA and the impact of foreign currency. Earnings releases are typically accompanied by conference call announcements where management discusses business trends, digital initiatives and regional performance.
Nature’s Sunshine also issues news on product launches and relaunches. Recent examples include the relaunch of its Power Line suite of metabolic health supplements—Power Beets, Power Greens, Power Meal and Power Balance—and recognition of Synergy WorldWide’s flagship product Pro-Argi-9+ as the world’s #1 L-arginine supplement in its category, based on Euromonitor International research.
Corporate governance and leadership developments feature prominently in NATR news, such as the appointment of a new Chief Executive Officer and senior supply chain leadership. In addition, the company reports on capital markets transactions, including secondary public offerings by major stockholders and related share repurchase agreements, as well as updates on joint venture arrangements and ownership changes in key international operations.
This news page aggregates these disclosures so readers can track Nature’s Sunshine’s financial performance, product pipeline, strategic initiatives and governance developments over time. For those researching NATR stock or the broader natural health and wellness space, the news flow provides context on how the company manages growth, regulatory complexity, supply chain operations and its global consultant and customer base.
Nature's Sunshine (NASDAQ:NATR) reported strong Q2 2025 financial results with net sales increasing 4% to $114.8 million compared to $110.6 million in the year-ago quarter. The company's GAAP net income rose significantly to $5.3 million ($0.28 per diluted share) from $1.3 million ($0.07 per diluted share).
Key performance metrics include Adjusted EBITDA growth of 8% to $11.3 million, improved gross profit margin of 71.7%, and strong performance in Japan and Central Europe. The company has revised its full-year 2025 guidance upward, now expecting net sales between $460-$475 million and adjusted EBITDA of $41-$45 million.
Nature's Sunshine Products (NASDAQ: NATR), a leading manufacturer of herbal and nutritional supplements, has scheduled its Q2 2025 earnings conference call for Thursday, July 31, 2025, at 5:00 p.m. ET. CEO Terrence Moorehead and CFO Shane Jones will host the call.
The company will release its financial results before the call, followed by a Q&A session. The call will be accessible via toll-free dial-in (1-800-717-1738) and international dial-in (1-646-307-1865) numbers. A replay will be available until August 14, 2025, and the call will be broadcast live on Nature's Sunshine's website.
Nature's Sunshine Products (NASDAQ: NATR) announced the pricing of a secondary public offering where Fosun Pharma USA will sell up to 2,854,607 shares of common stock at $12.00 per share. The offering is expected to close on June 27, 2025.
While NATR won't receive any proceeds from the offering, the company may purchase up to $15.0 million worth of shares from underwriters as part of its existing share repurchase program. D.A. Davidson & Co. is serving as the sole book-running manager for the offering.
Nature's Sunshine Products (NASDAQ: NATR) has announced a secondary public offering of up to 2,854,607 shares of common stock to be sold by Fosun Pharma USA. The company itself is not selling any shares and will not receive proceeds from the offering. As part of the offering, Nature's Sunshine may purchase up to $15.0 million of shares through its existing share repurchase program, funded by cash on-hand and credit facility.
D.A. Davidson & Co. is serving as the sole book-running manager for the offering, which is being made pursuant to an effective shelf registration statement filed with the SEC on June 9, 2025.
Nature's Sunshine Products (NASDAQ: NATR) has appointed Heidi Wissmiller as Chairman of the Board of Directors, effective April 30, 2025. Wissmiller, who has served on the board since 2020, succeeds Richard D. Moss, who retired after serving as Director since 2018 and Chairman since 2022.
As former Chief Growth Officer at Rodan + Fields, Wissmiller demonstrated significant achievements, including driving over $1 billion in incremental revenue growth and expanding the company's entrepreneur network to over 300,000 members. Her experience includes leadership roles at global companies like PepsiCo, E&J Gallo Winery, and Mondelez. She has previously chaired Nature's Sunshine's Governance and Risk Management Committees and currently serves as Chairman of the Board of Trustees of the New York Film Academy 10 ARTS Foundation.
Nature's Sunshine Products (NASDAQ: NATR) has released its 2024 Impact Report, highlighting significant environmental and sustainability achievements. The report details progress toward the company's 2025 ESG goals, including:
- Achieving TRUE Zero Waste Gold Certification for U.S. Distribution centers in May 2024
- Supporting over 1 million women and children with nutrition through partnerships
- Converting Spanish Fork manufacturing plant to 100% renewable energy
- Progress on reducing Scope 1 & 2 greenhouse gas emissions toward 50% reduction goal by 2025
- 32% waste reduction at manufacturing facilities since 2021
The report, titled 'Be More Earth,' aligns with the company's new marketing campaign and demonstrates their commitment to environmental stewardship and community engagement.
Nature's Sunshine Products (NATR) has scheduled its first quarter 2025 earnings conference call for Tuesday, May 6, 2025, at 5:00 p.m. Eastern time. The company will release its financial results for Q1 2025 (ended March 31, 2025) via press release before the call.
CEO Terrence Moorehead and CFO Shane Jones will host the conference call, which will include a Q&A session. Investors can join using the toll-free number 1-800-717-1738 or international number 1-646-307-1865 (Conference ID: 16234).
A replay will be available until May 20, 2025, through toll-free (1-844-512-2921) and international (1-412-317-6671) numbers with Replay ID 1116234. The call will also be broadcast live and archived on Nature's Sunshine's website.